Case Report: Acquired Disseminated BCG in the Context of a Delayed Immune Reconstitution After Hematological Malignancy - Gies, Vincent; Dieudonné, Yannick; Morel, Florence; Sougakoff, Wladimir; Carapito, Raphaël; Martin, Aurélie; Weingertner, Noëlle; Jacquel, Léa; Hubele, Fabrice; Kuhnert, Cornelia; Jung, Sophie; Schramm, Frederic; et al. (Frontiers in immunology, 2021)
Keywords: Administration, Intravesical; Antineoplastic Combined Chemotherapy Protocols - adverse effects; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Antitubercular Agents - therapeutic use; BCG; BCG Vaccine - administration & dosage; BCG Vaccine - adverse effects; BCGosis-susceptible PIDs; case report; contamination; Hematologic Neoplasms - drug therapy; hematological malignancies; Host-Pathogen Interactions; Human health and pathology; Humans; Immune Reconstitution; Immunocompromised Host; Immunodeficiency; Immunology; Life Sciences; Male; Middle Aged; Mycobacterium bovis - drug effects; Mycobacterium bovis - immunology; Mycobacterium bovis - pathogenicity; Opportunistic Infections - drug therapy; Opportunistic Infections - immunology; Opportunistic Infections - microbiology; Risk Factors; Treatment Outcome; Tuberculosis, Pulmonary - diagnosis; Tuberculosis, Pulmonary - drug therapy; Tuberculosis, Pulmonary - immunology; Tuberculosis, Pulmonary - microbiology; Urinary Bladder Neoplasms - drug therapy; Urinary Bladder Neoplasms - immunology; hematological malignancies; case report; BCGosis-susceptible PIDs; BCG; Immunodeficiency; contamination